Washington
+919359902383
+919359902383

Sutinat 12.5 mg Sunitinib Price USA | Ernest Impex Indian Exporter

Sutinat 12.5 mg Capsule: Precision Oncology Sourcing for Global Healthcare Networks



Are you searching for a trusted Sutinat 12.5 mg capsule exporter from IndiaErnest Impex, a pillar of the Group of Ernest Pharmaceutical Pvt. Ltd., is a leading global supplier and bulk distributor of targeted anticancer therapies. We facilitate a highly secure, temperature-controlled supply chain serving Washington (USA), London (UK), Bangkok (Thailand), Canberra (Australia), Singapore, and Kingston (Jamaica), ensuring that critical multi-kinase inhibitors are delivered with 100% pharmaceutical integrity.




Detailed Product Overview: What is Sutinat 12.5 mg?


Sutinat 12.5 mg Capsule is a low-dose oral formulation of Sunitinib, a potent multi-targeted tyrosine kinase inhibitor (TKI). Manufactured by Natco Pharma Ltd., a world-renowned leader in oncology generics, the 12.5 mg strength is essential for precise dose titration and maintaining therapeutic efficacy while managing patient-specific tolerability.

For international B2B procurement, Sutinat 12.5 mg is a vital component in treating advanced solid tumors, often used in combination with higher strengths or as a maintenance dose to optimize patient outcomes.




Primary Therapeutic Indications


Sutinat 12.5 mg is clinically utilized globally for the following:

  1. Gastrointestinal Stromal Tumor (GIST): For the treatment of patients whose disease has progressed or who are intolerant to Imatinib Mesylate.

  2. Advanced Renal Cell Carcinoma (RCC): A cornerstone therapy for metastatic kidney cancer.

  3. Pancreatic Neuroendocrine Tumors (pNET): For progressive, well-differentiated tumors in patients with unresectable locally advanced or metastatic disease.




Mechanism of Action: Advanced Signal Pathway Blockade


Sutinat 12.5 mg works by disrupting the biological signals that cancer cells require to grow and survive:

  • Multi-Receptor Inhibition: Sunitinib targets multiple receptor tyrosine kinases (RTKs), including all receptors for vascular endothelial growth factors (VEGFR-1, -2, -3) and platelet-derived growth factors (PDGFR-Ξ± and -Ξ²).

  • Anti-Angiogenic Activity: By inhibiting VEGFR, Sutinat prevents the tumor from developing the new blood vessels it needs to "feed" its growth, effectively starving the tumor.

  • Direct Growth Arrest: It binds to KIT (stem cell factor receptor) and FLT3, interrupting the internal signals that drive the rapid division of cancer cells.

  • Dual-Impact Therapy: This combination of starving the tumor and halting cell division makes it exceptionally effective against metastatic solid tumors.




Administration and Clinical Safety

  • Dosage Protocol: Sutinat 12.5 mg is taken orally, once daily. In GIST and RCC, it is typically administered on a "4 weeks on, 2 weeks off" schedule.

  • Storage: Store at room temperature (below 30Β°C). Keep the container tightly closed to protect the capsules from moisture and light.

  • Key Monitoring Parameters:

    • Cardiac Function: Regular monitoring of left ventricular ejection fraction (LVEF) is recommended.

    • Blood Pressure: Hypertension is a common side effect; patients require routine BP monitoring.

    • Thyroid Function: Routine screening for hypothyroidism is standard practice.

    • Hepatotoxicity: Periodic liver function tests (LFTs) are essential to ensure systemic safety.



Why Source Sutinat 12.5 mg from Ernest Impex?

  • Authentic Natco Oncology Exporter: Direct access to genuine Natco Pharma inventory, providing 100% authenticity and competitive bulk pricing.

  • Global Logistics Authority: We specialize in the complex documentation and cold-chain logistics required for Washington, London, Bangkok, Canberra, Singapore, and Kingston.

  • Regulatory Transparency: We provide all necessary B2B documentation, including GMP compliance, batch-specific COAs, and international export permits.

  • Supply Chain Resilience: In 2026, we prioritize digital traceability and secure fulfillment for hospital groups and regional distributors.



πŸ“ž Contact Ernest Impex β€” Pharmaceutical Exporter from India


[GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.]


🌐 Websites:

πŸ“§ Email: exports@ernestpharmaceuticals.com

πŸ“¦ Business Type: Exporter | Bulk Supplier | Distributor

πŸ“² WhatsApp: +91 93599 02383

πŸ”— Direct Link: Chat on WhatsApp

 2026-04-23T12:28:06

Keywords